Riskpilot← Back to searchSign inGet full accessOceanhamnens Vårdcentral AB
ABActiveOrg 5591860845Erik Dahlbergs Gata 91General medical practice activities · NACE 8621Est. 20185-9 employees
Revenue 2024
SEK 6,5M
+50% vs 2023
EBITDA margin
-13.8%
+59% vs 2023
Equity ratio
3.2%
Financial strength
Net profit 2024
SEK 2K
| Revenue | SEK 6,5M | +50% |
| EBITDA | SEK -893K | +59% |
| Net profit | SEK 2K | — |
| Total assets | SEK 1,4M | -4% |
| Equity | SEK 45K | +5% |
| Employees | — | — |
Legal name
Oceanhamnens Vårdcentral AB
Org number
5591860845
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
14 december 2018
Share capital
SEK 50 000
Employees
5-9
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas ensam av ledamoten Styrelsen ska bestå av 1 styrelseledamot och 1 styrelsesuppleant.
Company purpose
Bolaget skall bedriva hälso- och sjukvård samt äga och förvalta aktier jämte därmed förenlig verksamhet.
Address
Erik Dahlbergs Gata 91
Email
charlotte@hbgbmm.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 1 696 | 4 293 | 6 456 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −8 | — | −1 273 | −2 174 | −893 |
| Depreciation & amort. | −0 | −0 | −31 | −31 | −31 |
| EBIT | −8 | 0 | −1 304 | −2 205 | −924 |
| Net financials | — | — | — | — | −2 |
| Profit before tax | −8 | 0 | 1 | 0 | 3 |
| Tax | −0 | −0 | −0 | −0 | −1 |
| Net profit | −8 | 0 | 1 | 0 | 2 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 42 | 42 | 1 074 | 1 453 | 1 402 |
| Equity | 42 | 42 | 43 | 43 | 45 |
| Long-term debt | 0 | 0 | 385 | 541 | 311 |
| Short-term debt | 0 | 0 | 647 | 870 | 1 045 |
| Total debt | — | — | 1 032 | 1 411 | 1 356 |
EBITDA margin
-13.8%
This company
15.8%
Market median
-187% vs market
20202024
Equity ratio
3.2%
This company
38.2%
Market median
-92% vs market
20202024
Return on equity
4.4%
This company
18.4%
Market median
-76% vs market
20202024
Net profit margin
0.0%
This company
8.1%
Market median
-100% vs market
20202024
Asset turnover
4.60×
This company
1.12×
Market median
+311% vs market
20202024
Debt / equity
30.16×
This company
0.62×
Market median
-4765% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
YC Auditor Substitute | Auditor Substitute | 2024 |
| Audit | 2022 | |
| Former (1) | ||
OF Auditor Substitute | Auditor Substitute | 2022 – 2024 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Board of Directors | 2022 | |
| Former (1) | ||
| Deputy Board Member | 2022 – 2025 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Helsingborgs Familjecentral AB
Oceanhamnens Vårdcentral AB Board members of Oceanhamnens Vårdcentral AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Yvonne Cecilia Ståhl | Auditor Substitute | 0 companies |
| Lars Ludvigh Stensson Nyström | Audit | 0 companies |
| Ola Fredrik Andreas Johansson | Auditor Substitute | 0 companies |
| Kennert Allan Hugo Fröderberg | Deputy Board Member | 0 companies |
| Nina Charlotte Fröderberg | Board of Directors | 0 companies |